Spc Financial, Inc. Macrogenics Inc Transaction History
Spc Financial, Inc.
- $1.18 Billion
- Q2 2025
A detailed history of Spc Financial, Inc. transactions in Macrogenics Inc stock. As of the latest transaction made, Spc Financial, Inc. holds 37,750 shares of MGNX stock, worth $73,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,750
Previous 37,750
-0.0%
Holding current value
$73,235
Previous $47,000
4.26%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MGNX
# of Institutions
117Shares Held
52.3MCall Options Held
55.3KPut Options Held
35.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$19.2 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$11.6 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$10.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$8.17 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$6.31 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $119M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...